tiprankstipranks
pc:remep

Remepy

New York, NY, US
https://www.remepy.com/
Remepy develops hybrid drugs—therapeutic assets that combine conventional pharmaceutical agents with proprietary non‑pharmaceutical treatment protocols. The company applies AI-driven measurement and adaptation to deliver and optimize those protocols, operating at the intersection of drug development, digital therapeutics, and treatment personalization.

Leadership & Board

Key Executives
FounderMichal Tsur and Or Shoval
CSOAmir Amedi
CTOEran Etam
Current Number of Employees86
Current LinkedIn Followers7,412

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$46M
Total Amount Raised$46M
Total Funding Rounds2
Total Funding Rounds2
Latest Funding Amount$36M
Latest Funding Amount$36M
Latest Funding RoundSeries A
Latest Funding RoundSeries A
Post-Money Valuation
Post-Money Valuation

Employee Trend

Remepy had 86 employees as of August 31, 2026. The number of employees increased by 1 (1.18%) week-over-week.
86Latest Employee Count
1(1.18%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.

Social Trend

Remepy had 7,412 followers as of August 31, 2026. The number of followers increased by 97 (1.33%) week-over-week.
7,412Latest Followers Count
97(1.33%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Aug 12, 2026
Series A
$36.00M
Jun 01, 2024
Seed Round
$10.00M

Investors

Investor Name
Funding Round
Seed Round
Series A
Series A
Series A
Series A

Similar Companies

A snapshot of private companies similar to Remepy, helping you discover and navigate related company profiles.

Related News and Analysis